Skip to content
healthcare.dev

Theophylline (Anhydrous)

NDC 69367-415, Theophylline Anhydrous, tablet, extended release, from Westminster Pharmaceuticals, LLC.

Product NDC
69367-415
Status
Listed
Labeler
Westminster Pharmaceuticals, LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040560
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69367-415 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • THEOPHYLLINE ANHYDROUS600 mg/1

Pharmacologic classes

Methylxanthine [EPC]; Xanthines [CS]

Package NDCNDC-11Package
69367-415-0169367041501100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-415-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/04f1d1da-ce61-45b3-acf4-903cc81d16da
  • NADAC price for package 69367041501

    GET /v1/drugs/nadac/69367041501

Use it

Look up 69367-415 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69367-415 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69367-415. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.